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Abstract
The severity of an inﬂuenza epidemic season may be inﬂuenced not only by variability in the surface glycoproteins, but also by differ-
ences in the internal proteins of circulating inﬂuenza viruses. To better understand viral antigenic evolution, all eight gene segments
from 44 human H3N2 epidemic strains isolated during 2004–2008 in Taiwan were analyzed to provide a proﬁle of protein variability.
Comparison of the evolutionary proﬁles of the HA, NA and PB2 genes of inﬂuenza A (H3N2) viruses indicated that they were derived
from a group of H3N2 isolates ﬁrst seen in 2004. However, the PA, M and PB1 genes were derived from a different group of H3N2
isolates from 2004. Tree topology revealed the NP and NS genes could each be segregated into two groups similar to those for the
polymerase genes. In addition, new genetic variants occurred during the non-epidemic period and become the dominant strain after
one or two seasons. Comparison of evolutionary patterns in consecutive years is necessary to correlate viral genetic changes with anti-
genic changes as multiple lineages co-circulate.
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Introduction
Inﬂuenza viruses cause yearly epidemics worldwide in humans,
and are some of the most active pathogens in Taiwan leading
to signiﬁcant morbidity and mortality [1,2]. Conventionally,
analyses of inﬂuenza evolution have focused on individual viral
genes, most often HA, without exploring the interactions
among them. However, the evolutionary behaviour of the
virus often involves cooperative changes within and between
genes. Thus, there is important information about inﬂuenza
evolutionary behaviour that may be deduced from correlated
changes between nucleotide positions both within and
between genes.
With the cocirculation of different inﬂuenza A subtypes,
genetic reassortment can play an important role in antigenic
variation [3,4]. Reassortment of the eight segments of inﬂu-
enza A viruses can lead to complicated phylogenetic pat-
terns on the genomic scale [5–7]. Previous studies have
shown that the virulence and growth characteristics of
inﬂuenza viruses are inﬂuenced by changes in the internal
proteins [8,9]. The M1 protein is a multifunctional protein
that contributes to the control of virulence, growth [10–
13] and host speciﬁcity [14,15]. Changes in the NP, PB2
and M1 proteins were shown to play a role in host restric-
tion in monkeys [14]. Considering these observations, the
severity of an inﬂuenza epidemic season may be inﬂuenced
not only by variability in the surface glycoproteins, but also
by differences in the internal proteins of circulating inﬂu-
enza viruses. In the present study, we examined the evolu-
tionary dynamics of inﬂuenza A (H3N2) virus at genomic
and epidemiological scales, as isolated during 2004–2008 in
Taiwan, to provide a complete proﬁle of protein variability
as well as the viral antigenic evolutionary patterns of all
gene segments of these viruses.
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Materials and Methods
Isolates
Inﬂuenza strains circulating in 2004–2008 seasons were iso-
lated from combined nose and/or throat swabs from
selected patients with inﬂuenza-like illness presenting to phy-
sicians in sentinel practices (http://www.cdc.gov.tw). The
specimen were inoculated into Madin-Darby canine kidney
cells and were conﬁrmed by the indirect immunoﬂuores-
cence assay (IFA, Chemicon, Inc., Temecula, CA, USA) and
RT-PCR. RT-PCR reactions were performed as described
previously [16]. Supernatants from positive cultures were
harvested and stored at )80C for subsequent antigenic and
genetic analyses.
Genetic and antigenic analysis
Phylogeny construction and evaluation were performed with
the maximum likelihood and Neighbour-joining (NJ) methods
in the PHYLIP software [17]. Empirical transition/transversion
ratio was estimated by the TREE-PUZZEL software [18] to
calculate the evolutionary distances. To determine the over-
all selection pressures of each gene, we estimated the mean
numbers of nonsynonymous substitutions (dN) and synony-
mous substitutions (dS) per site (ratio dN/dS) using the SLAC
method within the HYPHY package [19] through the Datamon-
key web-based interface (http://www.datamonkey.org). The
dN/dS estimates were based on NJ trees under the GTR
substitution model. The full-genome sequences of 44 inﬂu-
enza A (H3N2) viruses obtained in the present study have
been submitted to GenBank and assigned accession numbers:
FJ805464–FJ805743.
Viruses were characterized by haemagglutination inhibition
(HI) assays, as described previously [20,21], using post-infec-
tion ferret antisera obtained from CDC, Atlanta, Georgia.
Results
Epidemic activities and antigenic analysis
Although the relative prevalence of inﬂuenza virus varies
from season to season, inﬂuenza A (H3N2) viruses were the
major epidemic strains isolated during the study period with
the exception of the 2005–2006 season. H3N2 viruses fre-
quently cocirculated with inﬂuenza B viruses as seen during
the 2004–2005 and 2006–2007 seasons in Taiwan (Fig. 1).
A total of 2080 samples that tested positive for inﬂuenza
viruses in the 2004–2005 season were conﬁrmed by RT-PCR.
Of these, 726 (34.9%) were inﬂuenza A (H3N2) viruses, 305
of which were selected for characterization in HI tests. Of
those HI analyzed, 172 (56.4%) were A/Wyoming/3/03-like,
with the remaining 133 (43.6%) isolates showing reduced
titres with antisera produced against A/Wyoming/3/03
(Fig. 2).
In the 2005–2006 season, a total of 858 samples tested
positive for inﬂuenza and 228 (26.6%) of these were H3N2.
Ninety-ﬁve isolates of the H3N2 positive samples were
selected for further characterization by HI testing. Of those
HI analyzed, 68 (71.6%) of them were A/California/7/04-like,
with the other 27 (28.4%) showing reduced titres with anti-
sera produced against A/California/7/04. In the subsequent
2006–2007 season, a total of 2175 samples tested positive
for inﬂuenza. Of these, 770 (35.4%) were H3N2, 213 of
which were selected for characterization in HI tests. Ninety-
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FIG. 1.Weekly distribution of Taiwanese inﬂuenza A (H3N2) isolates based on cell culture from 2004 to 2008, together with the positive rate
of culture conﬁrmed cases.
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four (44.1%) of them were A/Wisconsin/67/05-like, with the
remaining 119 (55.9%) having reduced titres with antisera
produced against A/Wisconsin/67/05.
Analysis of individual gene segments
HA and NA genes. Comparison of the amino acid sequences
encoded by the HA1 genes with that of the A/Wyoming/3/
03 vaccine strain revealed six conserved amino acid changes
(Table 1). The phylogenetic tree of these HA genes could be
divided into three subgroups according to different inﬂuenza
seasons: I, II and III (Fig. 3a). All isolates except those in sub-
group Ia had an additional S227P change. Two additional
amino acid changes at S193F and D225N were observed in
both groups II and III. Isolates within subgroup IIIb had four
additional changes at R142G, N144D, K173E and Y195H.
Isolates in group IIIa lacked those four amino acids changes
and could be further distinguished by an amino acid change
at position G50E.
Similar to the results seen for HA, NA genes could
be divided into three phylogenetic groups (Fig. 3b). This
observation suggested that the NA genes of recent H3N2
viruses, similar to their HA counterparts, have evolved as
two distinct phylogenetic branches. A total of 24 amino acid
substitution were observed compared to the NA gene of A/
Wyoming/3/03, and amino acid changes E199K, K221E and
Q432E became ﬁxed after 2004 (Table 1). The amino acids
composition of group II was similar to group I with the
exception of N93D, but differed from group III, which could
be distinguished by the signature change H150R. N93D,
V194I, Y310H L370S, S372L and N387K were signature
changes for NA group IIIa, whereas group IIIb viruses all had
changes at N86K, K296R, I307M and S335G. None of the
established genetic markers for neuraminidase drug resis-
tance at positions 119, 152, 274, 292 and 294 were found in
our NA dataset [22].
Polymerase PB2, PB1 and PA genes. In the phylogenetic tree of
the polymerase genes, the PB2 genes were divided into three
groups, Using the classiﬁcation of the HA genes, the PB2
genes of group Ia could be distinguished by amino acid
TABLE 1. Amino acid variation observed in HA1 and NA genes of human H3N2 viruses isolated from 2004 to 2008 in Taiwan
Protein
HA1 NA
50 128 142 144 145 159 173 186 189 193 195 219 225 227 86 93 150 194 199 221 296 307 310 335 370 372 387 432
Wyoming/03 G A R N K Y K V S S Y Y D S N N H V E K K I Y S L S N Q
I
Ia T N F G N S D K E E
Ib T N F G N S P D K E E
II T N F G N F S N P K E E
III
IIIa E T N F G N F S N P D R I K E H S L K E
IIIb T G D N F E G N F H S N P K R K E R M G E
(a)
(b)
FIG. 2. (a) Antigenic characterization of inﬂuenza viruses isolated from 2004 to 2007 in Taiwan. (b) Haemagglutination inhibition reactions of
inﬂuenza A (H3N2) virus using post-infection ferret antisera. Reference strains for 2004–2007 seasons, A/Wyoming/3/03, A/California/7/04, A/
Wisconsin/67/05, respectively.
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changes at T64I and T683A. An amino acid substitution
V461I was observed in group Ib, and the E249G amino acid
substitution distinguished group IIIb. The grouping of the PA
genes was similar to that seen for the PB1 gene (Fig. 3c,d,e).
When examining the deduced amino acid sequences of the
PB1 genes, all isolates had an N375S amino acid substitution,
and all except group Ib contained a V113A amino acid
change compared to A/Wyoming/3/03(Table 2). In addition,
all of the PA genes had the amino acid changes E101G,
I421V and Y437H, except for group Ib. An addition amino
acid substitution at S208T was seen in both groups II and III.
The subgroup Ib had unique changes at V62M, Q256K,
E382D and V602I (Table 2).
NP, M and NS genes. Phylogenetic analysis of the NP, M and
NS genes showed that these three genes of these viruses
could each be segregated into two groups similar to those
for the polymerase genes (Fig. 3f,g,h). Using the classiﬁcation
used for the HA genes (above), three amino acid substitu-
tions (Y52H, V280A and V312I) were observed in the NP
genes of both group Ib and group IIIa. The amino acid substi-
tution S377G was present in all isolates except those in
group Ib and additional amino acid changes at K31R and
E495K were observed in group IIIb.
Signature change associated with adamantanes resistance
S31N in M2 gene became ﬁxed after 2004 in all isolates
except those in group Ib. Group IIIb could be distinguished
by the amino acid change T239N in the M1 gene and P10T
and G58S changes in the M2 gene. The NS1 genes of Tai-
wanese isolates all have the V124M amino acid difference
compared to A/Wyoming/3/03, with group IIIa having an
additional amino acid change at K221E (Table 2). There were
no changes in NS2 compared to the A/Wyoming/3/03 vac-
cine strain.
Measurement of selection pressures
The selection pressures acting on human H3N2 viruses were
higher than for previous reports [23,24]. The highest dN/dS
ratios were observed in the HA and NA (mean dN/dS 0.41
and 0.37, respectively), most likely reﬂecting immune selec-
tion pressure at a small number of amino acid sites [25], and
also NP, NS and M (mean dN/dS 0.08, 0.32, and 0.08, respec-
tively), which are essential for transcription and replication.
Discussion
To date, molecular and phylogenetic analyses of inﬂuenza A
H3N2 viruses spanning successive seasons have not been
reported in Taiwan. The changing patterns of genetic diver-
sity in viral isolates provide insight into the seasonal dynam-
ics of inﬂuenza A and reveal the evolutionary interaction
between subtypes; for example, recent seasons dominated
by H1N1 were observed following H3N2 epidemics (Fig. 1).
The amino acids in the H3 HA1 from 2004 to 2008 had a
total of 17 amino acid substitutions, all of which were
located at well known antibody antigenic sites or receptor
binding sites.
Changes in the 140–146 region of antigenic site A are
characteristic for antigenically distinct viruses of epidemic sig-
niﬁcance [26]. The amino acid substitution K145N has been
ﬁxed subsequent to the 2004–2005 season and we found
two additional amino acid changes, R142G and N144D, in
the antigenic site A of viruses isolated in 2007. Moreover,
one region in HA at amino acids 225–227, which affects anti-
genic site D, changed dramatically during the study period as
a result of D225N and S227P mutations. The 225 and 227
positions are also located in the receptor binding pocket and
thus could be expected to have effects beyond antigenic vari-
ation. Two amino acid substitutions at positions 128 (A to T;
position 126–128 are N,W and T) and 144 (N to D; position
144–146 are D,N and S) were observed that could affect
N-linked glycosylation, which could conceivably allow escape
from human immune pressure.
The NA genes of the A/Hiroshima/52/05 reference strain
apparently evolved along a separate evolutionary pathway
TABLE 2. Amino acid variation observed in the internal genes of human H3N2 viruses isolated from 2004 to 2008 in Taiwan
Protein
PB2 PB1 PA NP M1 M2 NS1
64 249 461 683 113 375 586 621 642 62 101 208 256 382 421 437 602 31 52 280 312 377 495 174 219 239 10 31 58 124 221
Wyoming/03 T E V T V N R R N V E S Q E I Y V K Y V V S E R I T P S G V K
I
Ia I A A S S G V H G N M
Ib I S Q M K D I H A I K V M
II A S G T V H G N M
III
IIIa A S K G T V H H A I G N M E
IIIb G A S G T V H R G K N T N S M
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and cocirculated with A/California/7/04-like and A/Wiscon-
sin/67/05-like viruses between 2004 and 2007, thus providing
an opportunity for mixed infections that might lead to the
emergence of reassortants. These reassortants would not be
expected to have any increased epidemic potential compared
to their parents and, at this stage, there is no deﬁnitive evi-
dence that the inﬂuenza A H3N2 reassortant viruses were
more virulent than the nonreassortant ones in terms of clini-
cal outcomes. A previous study suggested that new antigenic
variants may arise from changes that affect N2 antigenic site
B [27]. H3N2 viruses isolated from Taiwan possessed E199K
and K221E changes in the NA gene, both of which are found
in antigenic site B. We also detected amino acid substitutions
in the neuraminidase gene that were not associated with cat-
alytic or framework sites, and none of the neuraminidase
substitutions conferring resistance to neuraminidase inhibi-
tors have been observed in our study. Similarly, we did not
observe amino acid changes in the N2 protein that would be
expected to lead to a decrease in virus replication in eggs
[28]; the amino acids known to allow efﬁcient replication in
eggs (Q119, K136 and Y347) were all present in the viruses
examined.
Comparison of the evolutionary proﬁles of the HA, NA,
and PB2 genes of inﬂuenza A (H3N2) viruses revealed that
these genes of 2005–2008 isolates were derived from iso-
lates having the group Ib HA gene, and PA, M and PB1 genes
were derived from group Ia isolates of the 2004–2005 sea-
son. The phylogenetic trees of HA and NA showed seasonal
clusters but also co-circulating lineages within each season. It
should be noted that, in the 2006–2007 season, the HA, NA,
PA, PB1 and M genes of three viruses (A/Taiwan/799/2006,
A/Taiwan/448/2007 and A/Taiwan/449/2007) were in group
IIIa but the PB2 and NP genes were in group Ib. These new
genetic variants were detected during the 2006 and 2007
non-epidemic periods and the reassortants isolated in 2006
were antigenically similar to A/California/7/04; however, the
reassortants isolated in 2007 demonstrated a four-fold HI
difference compared to A/Hiroshima/52/2005, both of which
were vaccine strains recommended for the 2005–06 and
2006–07 season, respectively. Indeed, these reassortant
viruses continued to be isolated and become the dominant
strains during year 2008 (Fig. 3).
Reassortment among co-circulating H3N2 viruses similar
to that observed in present study has been described previ-
ously, including reassortment of the NA gene segment [29]
and the internal segments [30–33]. However, a different
phylogenetic pattern from previous report is observed dur-
ing the 2007–08 season, and such a major difference in the
phylogenetic signal strongly suggests that H3N2 viruses
evolve rapidly, as a result not only of genetic drift, but also
natural selection. The complete genome analysis of recently
sampled Taiwan A (H3N2) inﬂuenza viruses in the present
study has revealed the co-circulation of multiple distinct
groups and frequent intra-subtype reassortment events
among them, and such evolution plays an important role in
antigenic drift.
In addition, the data presented here reveal that the M2
proteins in all groups except group Ib possessed the substi-
tution S31N. It is interesting to note that all isolates with
this S31N amino acid change also have amino acid substitu-
tions in PA and PB1 genes, including E101G, S208T, K256Q,
D382D, I421I and Y437H in PA, and the V113A amino acid
change in PB1. The role of PA is not well established,
although it is known to be involved in RNA replication
[34,35]. Recent studies indicate that PA is likely to be
involved in transcription as well as replication [36,37]. It has
also been reported that the N-terminal region of PA plays a
critical role in multiple functions, such as cap-binding, endo-
nuclease activity, etc. [38].
Genetic analyses of inﬂuenza H3N2 viruses provide infor-
mation that is important for understanding the mechanisms
involved in the emergence of pandemic inﬂuenza viruses. The
present study covered the phylogenetic relationships of the
external as well as internal genes and clearly demonstrates
the value of analyzing the complete genetic composition of
inﬂuenza viruses in order to understand fully the evolution-
ary mechanisms and epidemiology of inﬂuenza. Furthermore,
the present study explores in detail a reassortment event in
internal genes leading to an epidemiologically signiﬁcant out-
come, namely the emergence of the ‘2008–2009 epidemic
strain’ in the 2006–2007 season. Importantly, the data pre-
sented here provide evidence suggestign that inﬂuenza A
H3N2 viruses undergo internal gene reassortment and that
important evolutionary processes may occur during non-epi-
demic periods at least one or two season ahead. Although it
is not yet clear how variant clades manage to persist along-
side dominant strains, the fact that they do suggests the
inﬂuenza virus has multiple adaptive abilities. The overall
selection pressure also reveals that the former have not yet
reached a global ﬁtness peak characterized by little amino
acid ﬁxation.
Analyses of the genetic and antigentic data, together
with epidemiological data for the sequenced isolates, have
provided insights into the pattern of virus spread, the genetic
diversity during seasonal epidemics, and the dynamics of
subtype evolution. Continuous monitoring of viral genetic
changes throughout consecutive years is necessary to formu-
late hypotheses as to why antigenic evolution allows cer-
tain variants to become dominant when multiple lineages
co-circulate.
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